The mRNA technology from COVID-19 vaccines may help amplify cancer treatments that use the body’s own immune system to fight cancer, a new study has found.
Cancer patients who received an mRNA-based jab, for example, those made by Pfizer or Moderna, within 100 days of starting immunotherapy fared much better than those who were not vaccinated.
Cancer immunotherapies train the body’s immune system to recognise and destroy tumours.
Continue Reading on Euronews
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.